NEUPRO Side Effects

7022232-9 | Chronic Obstructive Pulmonary Disease, Condition Aggravated, Delirium, Emphysema, Fall, Femur Fracture
on Sep 15, 2010 Female patient from GERMANY , weighting 99.21 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease, condition aggravated, delirium, emphysema, fall (What is fall?), femur fracture. Neupro dosage: (2 Mg Qd Transdermal), (4 Mg Qd Transdermal), (6 Mg Qd Transdermal). During the same period patient was treated with CARBIDOPA AND LEVODOPA ((100/25 Mg Once Daily), (200/50 Mg Once Daily), (200/50 Mg Twice Daily)) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ). Patient was hospitalized.

7021661-7 | Condition Aggravated, Parkinson's Disease, Treatment Noncompliance
Patient was taking Neupro (View Usage). Patient had the following side effects: condition aggravated, parkinson's disease (What is parkinson's disease?), treatment noncompliance on Sep 17, 2010 from GERMANY Additional patient health information: Male patient , weighting 176.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: (6 Mg Qd) ; (8 Mg Qd) ; (4 Mg Qd) ; (8 Mg Qd) ; (12 Mg Qd) ; (10 Mg Qd) ; (8 Mg Qd). During the same period patient was treated with LEVOCOMP (View Levocomp Review and Levocomp Label ), MADOPAR LT (View Madopar Lt Review and Madopar Lt Label ). Patient was hospitalized.

7021596-X | Concussion, Erythema, Polyneuropathy, Somatoform Disorder, Spinal Column Stenosis
Adverse event was reported on Sep 16, 2010 by a Female patient taking Neupro (View Usage) (Dosage: 3 Mg Qd Transdermal) was diagnosed with restless legs syndrome and. Location: GERMANY , weighting 163.1 lb, After Neupro was administered, patient had the following side effects: concussion (What is concussion?), erythema, polyneuropathy, somatoform disorder, spinal column stenosis. During the same period patient was treated with EFEROX (View Eferox Review and Eferox Label ), LAFAMME (View Lafamme Review and Lafamme Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), NOVAMINSULFON (View Novaminsulfon Review and Novaminsulfon Label ).

7020368-X | Gestational Diabetes, Pregnancy, Premature Labour
on Sep 16, 2010 Female patient from GERMANY , 26 years of age, was diagnosed with restless legs syndrome and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: gestational diabetes, pregnancy (What is pregnancy?), premature labour. Neupro dosage: Transdermal. During the same period patient was treated with RIVOTRIL (RIVOTRIL) (NOT SPECIFIED) (View Rivotril (rivotril) (not Specified) Review and Rivotril (rivotril) (not Specified) Label ).


7020367-8 | Meningitis, Premature Baby
on Sep 16, 2010 Female patient from GERMANY , weighting 4.63 lb, was diagnosed with restless legs syndrome and was treated with Neupro (View Usage). Patient had the following side effects: meningitis (What is meningitis?), premature baby. Neupro dosage: Transplacental. During the same period patient was treated with RIVOTRIL ((RIBOTRIL) (NOT SPECIFIED) (Transplacental) (View Rivotril ((ribotril) (not Specified) Review and Rivotril ((ribotril) (not Specified) Label ).

7018590-1 | Atrial Fibrillation, Electrocardiogram Abnormal, Hyperkalaemia
Patient was taking Neupro (View Usage). After Neupro was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), electrocardiogram abnormal, hyperkalaemia on Sep 15, 2010 from GERMANY Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: (2 Mg Qd Transdermal), 4 Mg Qd Transdermal, 6 Mg Qd Transdermal. During the same period patient was treated with CARBIDOPA + LEVODOPA (View Carbidopa + Levodopa Review and Carbidopa + Levodopa Label ).

6979441-4 | Constipation, Malabsorption, Pneumonia Aspiration, Product Adhesion Issue, Product Quality Issue, Pyrexia, Seborrhoea, Unevaluable Event
Adverse event was reported on Aug 27, 2010 by a Male patient taking Neupro (View Usage) (Dosage: (16 Mg, 2 X 8 Mg Patches Transdermal)) . Location: UNITED KINGDOM , 75 years of age, Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), malabsorption, pneumonia aspiration, product adhesion issue, product quality issue, pyrexia, seborrhoea, unevaluable event. Patient was hospitalized.

6979438-4 | Dizziness, Fall, Femur Fracture, Hypotension, Transient Ischaemic Attack
on Aug 30, 2010 Female patient from ROMANIA , weighting 99.21 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), hypertension and was treated with Neupro (View Usage). Patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), femur fracture, hypotension, transient ischaemic attack. Neupro dosage: (2 Mg Qd Transdermal). During the same period patient was treated with ISICOM (ISICOM) (NOT SPECIFIED) ((125 Mg 6x/day)) (View Isicom (isicom) (not Specified) Review and Isicom (isicom) (not Specified) Label ), ENALAPRIL MALEATE ((10 Mg Bid)) (View Enalapril Maleate Review and Enalapril Maleate Label ), INDAPAMIDE (RAWEL) ((1.5 Mg Qd)) (View Indapamide (rawel) Review and Indapamide (rawel) Label ). Patient was hospitalized and became disabled.

6970438-7 | Concussion, Rash, Spinal Column Stenosis
on Aug 26, 2010 Female patient from GERMANY , weighting 163.1 lb, was diagnosed with restless legs syndrome and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: concussion (What is concussion?), rash (What is rash?), spinal column stenosis. Neupro dosage: 3 Mg Qd Transdermal. During the same period patient was treated with EFEROX (View Eferox Review and Eferox Label ), LAFAMME (View Lafamme Review and Lafamme Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), NOVAMINSULFON (View Novaminsulfon Review and Novaminsulfon Label ).

6970131-0 | Electrocardiogram Qt Prolonged
Patient was taking Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged on Aug 20, 2010 from GERMANY Additional patient health information: Male patient , weighting 178.6 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: (2 Mg Qd), (4 Mg Qd), (6 Mg Qd), (8 Mg Qd). During the same period patient was treated with AMANTADINE HCL (View Amantadine Hcl Review and Amantadine Hcl Label ), AZILECT (View Azilect Review and Azilect Label ), PARKINSAN (View Parkinsan Review and Parkinsan Label ), MAGNESIUM (View Magnesium Review and Magnesium Label ), DELMUNO (View Delmuno Review and Delmuno Label ).

6970129-2 | Bradycardia
Adverse event was reported on Aug 30, 2010 by a Female patient taking Neupro (View Usage) (Dosage: 2 Mg Qd) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GREECE , 75 years of age, Patient had the following side effects: bradycardia. Patient was hospitalized.

6970127-9 | Electrocardiogram Qt Prolonged
on Aug 20, 2010 Female patient from GERMANY , weighting 132.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: electrocardiogram qt prolonged. Neupro dosage: 2 Mg Qd, 4 Mg Qd, 6 Mg Qd, 8 Mg Qd, 10 Mg Qd, 12 Mg Qd, 10 Mg Qd, 8 Mg Qd. During the same period patient was treated with PARKINSAN (PARKKINSAN) ((10 Mg Tid), (10 Mg Bid), (10 Mg Qd)) (View Parkinsan (parkkinsan) Review and Parkinsan (parkkinsan) Label ).

6929278-7 | Delirium
on May 19, 2010 Male patient from SPAIN , weighting 149.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: delirium. Neupro dosage: (transdermal) ; (increased Dose Transdermal). During the same period patient was treated with SINEMET ((125 Mg Tid Oral)) (View Sinemet Review and Sinemet Label ).

6915694-6 | Restless Legs Syndrome
Patient was taking Neupro (View Usage). Patient had the following side effects: restless legs syndrome on Jul 29, 2010 from GERMANY Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with restless legs syndrome and. Neupro dosage: 2 Mg Qd Transdermal. During the same period patient was treated with TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6909532-5 | Hypotension
Adverse event was reported on Jul 23, 2010 by a Male patient taking Neupro (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 80 years of age, After Neupro was administered, patient had the following side effects: hypotension. During the same period patient was treated with SINEMET (View Sinemet Review and Sinemet Label ). Patient was hospitalized.

6898073-X | Orthostatic Hypertension
on Jul 19, 2010 Female patient from SPAIN , 80 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: orthostatic hypertension. Neupro dosage: 4 Mg 1x/24 Hours Transdermal. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6894253-8 | Upper Limb Fracture
on Jul 20, 2010 Female patient from GERMANY , weighting 116.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient had the following side effects: upper limb fracture. Neupro dosage: (2mg Qd Transdermal), (4 Mg Qd Transdermal), (6 Mg Qd Transdermal), (8 Mg Qd Transdermal). During the same period patient was treated with SIMVASTIN MEPHA (View Simvastin-mepha Review and Simvastin-mepha Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6883242-5 | Cardiac Failure, Cyanosis, Dyspnoea, Haematoma, Loss Of Consciousness, Oedema Peripheral
Patient was taking Neupro (View Usage). After Neupro was administered, patient had the following side effects: cardiac failure, cyanosis, dyspnoea, haematoma, loss of consciousness, oedema peripheral on Jul 14, 2010 from GERMANY Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), hypertension, cardiac disorder, arrhythmia (What is arrhythmia?) and. Neupro dosage: (1 Mg Qd Transdermal), 93 Mg Qd Transdermal), (4 Mg Qd Transdermal). During the same period patient was treated with ISOKET (ISOKET) ((20 Mg Bid)) (View Isoket (isoket) Review and Isoket (isoket) Label ), TORASEMID (TORASEMID) (NOT SPECIFIED) ((10 Mg Bid)) (View Torasemid (torasemid) (not Specified) Review and Torasemid (torasemid) (not Specified) Label ), DIGITOXIN INJ ((0.07 Mg Qd)) (View Digitoxin Inj Review and Digitoxin Inj Label ), ASS (ASS) (NOT SPECIFIED) ((100 Mg Qd)) (View Ass (ass) (not Specified) Review and Ass (ass) (not Specified) Label ), BISOPROLOL FUMARATE ((5 Mg Qd)) (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), DIOVAN ((160 Mg Qd)) (View Diovan Review and Diovan Label ). Patient was hospitalized.

6874805-1 | Fatigue, Hyperglycaemia, Insulin Resistance, Renal Failure, Sleep Attacks
Adverse event was reported on Jul 12, 2010 by a Male patient taking Neupro (View Usage) (Dosage: (2 Mg Qd Transdermal) , (4 Mg Qd Transdermal)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , weighting 275.6 lb, Patient experienced the following unwanted or unexpected effects: fatigue, hyperglycaemia, insulin resistance, renal failure, sleep attacks. During the same period patient was treated with AMANTADINE HCL ((100 Mg Qd Oral), (200 Mg Qd Oral) , (100 Mg Tid, Other 2-1-0 Oral)) (View Amantadine Hcl Review and Amantadine Hcl Label ), CARBIDOPA AND LEVODOPA ((dose Oral) , (100/25 As Given Dose, Frequency - Other 1/2-0-0 Oral) , (100/25 As Given Dose, Frequ) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ). Patient was hospitalized.

6870146-7 | Condition Aggravated, Parkinson's Disease
on Jul 09, 2010 Male patient from GERMANY , weighting 187.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient had the following side effects: condition aggravated, parkinson's disease (What is parkinson's disease?). Neupro dosage: (2 Mg Qd Transdermal), (4 Mg Qd Transdermal), (6 Mg Qd Transdermal). During the same period patient was treated with DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), CIITALOPRAM (View Ciitalopram Review and Ciitalopram Label ), EXELON (View Exelon Review and Exelon Label ). Patient was hospitalized.

6864937-6 | Orthostatic Hypertension
on Jul 12, 2010 Female patient from SPAIN , 80 years of age, weighting 154.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?), epilepsy (What is epilepsy?) and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: orthostatic hypertension. Neupro dosage: (4 Mg 1x/24 Hours Transdermal). During the same period patient was treated with KEPPRA ((500 Mg Bid Oral)) (View Keppra Review and Keppra Label ), ADIRO (View Adiro Review and Adiro Label ).

6838612-8 | Hallucination, Hypersexuality, Jealous Delusion, Libido Increased, Restlessness
Patient was taking Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, hypersexuality, jealous delusion, libido increased, restlessness on Jul 09, 2010 from GERMANY Additional patient health information: Male patient , weighting 222.0 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: Transdermal, 8 Mg Qd, Transdermal, 8 Mg Qd Transdermal. During the same period patient was treated with CARBIDOPA AND LEVODOPA (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ). Patient was hospitalized.

6782823-7 | Convulsive Threshold Lowered, Disorientation, Eye Rolling, Foaming At Mouth, Loss Of Consciousness, Nausea, Urinary Incontinence
Adverse event was reported on Jun 08, 2010 by a Female patient taking Neupro (View Usage) (Dosage: (transdermal)) . Location: UNITED KINGDOM , 71 years of age, Patient had the following side effects: convulsive threshold lowered, disorientation, eye rolling, foaming at mouth, loss of consciousness, nausea (What is nausea?), urinary incontinence (What is urinary incontinence?). During the same period patient was treated with CO CARELDOPA (View Co-careldopa Review and Co-careldopa Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ).

6767720-5 | Acute Respiratory Failure
on Jun 03, 2010 Male patient from UNITED KINGDOM , 78 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: acute respiratory failure. Neupro dosage: 10 Mg Qd Transdermal. During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), HYDROXOCOBALAMIN (View Hydroxocobalamin Review and Hydroxocobalamin Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), CO BENELDOPA (View Co-beneldopa Review and Co-beneldopa Label ), CO CARELDOPA (View Co-careldopa Review and Co-careldopa Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ).

6764092-7 | No Adverse Event
on May 28, 2010 Female patient from GERMANY , weighting 198.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: no adverse event. Neupro dosage: 4 Mg Qd Transdermal. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ). Patient was hospitalized.

6759724-3 | Groin Pain, Hypothyroidism, Pain In Extremity
Patient was taking Neupro (View Usage). Patient had the following side effects: groin pain, hypothyroidism, pain in extremity on May 25, 2010 from GERMANY Additional patient health information: Female patient , 59 years of age, was diagnosed with neuroborreliosis and. Neupro dosage: (transdermal). During the same period patient was treated with GRUNCEF (GRUNCEF) (View Gruncef (gruncef) Review and Gruncef (gruncef) Label ), AZILECT (View Azilect Review and Azilect Label ). Patient was hospitalized.

6754741-1 | Abdominal Discomfort, Dyskinesia, Hallucination, Visual
Adverse event was reported on May 14, 2010 by a Male patient taking Neupro (View Usage) (Dosage: (8 Mg Qd Transdermal)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , 70 years of age, weighting 176.4 lb, After Neupro was administered, patient had the following side effects: abdominal discomfort, dyskinesia, hallucination, visual. During the same period patient was treated with MADOPAR /00349201/ (MADOPAR) ((100 Mg 8x/day, Single Dose 100mg Oral)) (View Madopar /00349201/ (madopar) Review and Madopar /00349201/ (madopar) Label ). Patient was hospitalized.

6751542-5 | Accident, Fall, Sudden Onset Of Sleep
on May 19, 2010 Female patient from GERMANY , 50 years of age, was diagnosed with restless legs syndrome and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: accident, fall (What is fall?), sudden onset of sleep. Neupro dosage: .

6744191-6 | Arthropathy, Motor Dysfunction
on May 14, 2010 Male patient from GERMANY , weighting 216.1 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient had the following side effects: arthropathy, motor dysfunction. Neupro dosage: 4 Mg Qd Transdermal, 6 Mg Qd Transdermal. During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

6742198-6 | Hospitalisation
Patient was taking Neupro (View Usage). After Neupro was administered, patient had the following side effects: hospitalisation on May 12, 2010 from GERMANY Additional patient health information: Female patient , weighting 160.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: 16 Mg Qd Transdermal. During the same period patient was treated with REQUIP (4 Mg Qd) (View Requip Review and Requip Label ), STALEVO 100 (100 Mg Bid, 100 Mg Qod) (View Stalevo 100 Review and Stalevo 100 Label ), NACOM (NACOM) (100 Mg Qid, 100 Mg Bid, 100 Mg Qd) (View Nacom (nacom) Review and Nacom (nacom) Label ), SIFROL (SIFROL) (NOT SPECIFIED) (0.7 Mg, 1-0.5-1-0-1; 0.52 Mg Qd; 1.05 Qd; 2.1 Mg Qd) (View Sifrol (sifrol) (not Specified) Review and Sifrol (sifrol) (not Specified) Label ). Patient was hospitalized.

6740334-9 | Pulmonary Embolism
Adverse event was reported on May 14, 2010 by a Female patient taking Neupro (View Usage) (Dosage: (2 Mg 4d), (4 Mg Qd)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with RESTEX (View Restex Review and Restex Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), ENAHEXAL /00574902/ (View Enahexal /00574902/ Review and Enahexal /00574902/ Label ), OMEPRAZOL /00661203/ (View Omeprazol /00661203/ Review and Omeprazol /00661203/ Label ), MIANSERIN (View Mianserin Review and Mianserin Label ). Patient was hospitalized.

6738397-X | Cognitive Disorder, Confusional State, Psychomotor Hyperactivity
on May 07, 2010 Male patient from SPAIN , weighting 121.3 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient had the following side effects: cognitive disorder, confusional state, psychomotor hyperactivity. Neupro dosage: 8 Mg Qd Transdermal. During the same period patient was treated with CITALOPRAM HYDROBROMIDE (20 Mg Qd Oral) (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ).

6738396-8 | Delirium
on May 10, 2010 Male patient from SPAIN , weighting 149.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: delirium. Neupro dosage: Transdermal, Increased Dose Transdermal. During the same period patient was treated with SINEMET (125 Mg Tid Oral) (View Sinemet Review and Sinemet Label ).

6732704-X | Nausea, Urine Output Increased, Weight Decreased
Patient was taking Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), urine output increased, weight decreased on May 06, 2010 from GERMANY Additional patient health information: Female patient , 44 years of age, weighting 143.3 lb, was diagnosed with restless legs syndrome and. Neupro dosage: (3 Mg 1x/24 Hours Transdermal). During the same period patient was treated with COPAXONE (View Copaxone Review and Copaxone Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ).

6727777-4 | Arteriosclerosis, Bile Duct Stone, Confusional State, Depression, Helicobacter Gastritis, Hyperhidrosis, Leukocyturia, Nephrolithiasis, Nightmare
Adverse event was reported on Apr 26, 2010 by a Female patient taking Neupro (View Usage) (Dosage: (4 Mg 1x/24 Hours)) . Location: GERMANY , weighting 187.4 lb, Patient had the following side effects: arteriosclerosis, bile duct stone, confusional state, depression (What is depression?), helicobacter gastritis, hyperhidrosis, leukocyturia, nephrolithiasis, nightmare. During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ALLOBETA (View Allobeta Review and Allobeta Label ), LYRICA (View Lyrica Review and Lyrica Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), MADOPAR (View Madopar Review and Madopar Label ). Patient was hospitalized.

6727774-9 | Embolism
on May 03, 2010 Female patient from GERMANY , 80 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: embolism. Neupro dosage: . During the same period patient was treated with STALEVO 100 (View Stalevo 100 Review and Stalevo 100 Label ).

6703445-X | Bile Duct Stone, Confusional State, Helicobacter Gastritis, Hyperhidrosis, Hypophagia, Nightmare, Restlessness, Sleep Talking
on Apr 14, 2010 Female patient from GERMANY , weighting 176.4 lb, was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: bile duct stone, confusional state, helicobacter gastritis, hyperhidrosis, hypophagia, nightmare, restlessness, sleep talking. Neupro dosage: (4 Mg). During the same period patient was treated with LEVODOPA (View Levodopa Review and Levodopa Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ALLOBETA /00003301/ (View Allobeta /00003301/ Review and Allobeta /00003301/ Label ), LYRICA (View Lyrica Review and Lyrica Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

6691314-3 | Condition Aggravated, Parkinson's Disease, Product Quality Issue
Patient was taking Neupro (View Usage). Patient had the following side effects: condition aggravated, parkinson's disease (What is parkinson's disease?), product quality issue on Oct 21, 2009 from UNITED KINGDOM Additional patient health information: Male patient , weighting 187.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: 4 Mg Qd Transdermal, 8 Mg 1x/24 Hours Transdermal. During the same period patient was treated with MADOPAR /00349201/ (View Madopar /00349201/ Review and Madopar /00349201/ Label ), METFORMIN (View Metformin Review and Metformin Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ), ALENDRONIC ACID (View Alendronic Acid Review and Alendronic Acid Label ), CALCIUM D3 /01483701/ (View Calcium D3 /01483701/ Review and Calcium D3 /01483701/ Label ).

6686232-0 | Depression, Fatigue, Headache, Nausea
Adverse event was reported on Mar 31, 2010 by a Male patient taking Neupro (View Usage) (Dosage: See Image) was diagnosed with restless legs syndrome and. Location: GERMANY , weighting 174.2 lb, After Neupro was administered, patient had the following side effects: depression (What is depression?), fatigue, headache (What is headache?), nausea (What is nausea?). During the same period patient was treated with DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), TEBONIN /01003104/ (View Tebonin /01003104/ Review and Tebonin /01003104/ Label ), MAGNESIUM DIASPORAL (View Magnesium Diasporal Review and Magnesium Diasporal Label ), SORTIS /01326101/ (View Sortis /01326101/ Review and Sortis /01326101/ Label ), EZETROL (View Ezetrol Review and Ezetrol Label ).

6662534-9 | Depression, Fatigue, Headache, Nausea
on Mar 16, 2010 Male patient from GERMANY , weighting 174.2 lb, was diagnosed with restless legs syndrome and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: depression (What is depression?), fatigue, headache (What is headache?), nausea (What is nausea?). Neupro dosage: 4 Mg Transdermal, 1 Mg Transdermal, 1.5 Mg Transdermal. During the same period patient was treated with DILTIAZEM MEPHA 90 RETARD (View Diltiazem-mepha 90 Retard Review and Diltiazem-mepha 90 Retard Label ), TEBONIN /01003104/ (View Tebonin /01003104/ Review and Tebonin /01003104/ Label ), MAGNESIUM DIASPORAL (View Magnesium Diasporal Review and Magnesium Diasporal Label ), SAW PALMETTO /00833501/ (View Saw Palmetto /00833501/ Review and Saw Palmetto /00833501/ Label ), SORTIS /01326101/ (View Sortis /01326101/ Review and Sortis /01326101/ Label ), EZETROL (View Ezetrol Review and Ezetrol Label ).

6662514-3 | Gastrointestinal Disorder, Granuloma, Lung Disorder, Pleural Effusion, Pulmonary Sarcoidosis
on Mar 24, 2010 Female patient from GERMANY , weighting 138.9 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient had the following side effects: gastrointestinal disorder, granuloma, lung disorder, pleural effusion, pulmonary sarcoidosis. Neupro dosage: (6 Mg Qd Cutaneous). During the same period patient was treated with MADOPAR /00349201/ (View Madopar /00349201/ Review and Madopar /00349201/ Label ). Patient was hospitalized.

6662513-1 | Akinesia, Condition Aggravated, Gait Disturbance, Parkinson's Disease
Patient was taking Neupro (View Usage). After Neupro was administered, patient had the following side effects: akinesia, condition aggravated, gait disturbance, parkinson's disease (What is parkinson's disease?) on Mar 19, 2010 from GERMANY Additional patient health information: Male patient , weighting 180.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: (2 Mg Qd Transdermal), (4 Mg Qd Transdermal), (6 Mg Qd Transdermal). During the same period patient was treated with STALEVO 100 ((15/37.5 /200 Mg Three Times Daily)) (View Stalevo 100 Review and Stalevo 100 Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), OXYBUTYNIN (View Oxybutynin Review and Oxybutynin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6662512-X | Anxiety, Bradyphrenia, Chills, Cognitive Disorder, Condition Aggravated, Decreased Activity, Depression, Dizziness
Adverse event was reported on Mar 18, 2010 by a Male patient taking Neupro (View Usage) (Dosage: (8 Mg Qd Transdermal)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , weighting 183.0 lb, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), bradyphrenia, chills, cognitive disorder, condition aggravated, decreased activity, depression (What is depression?), dizziness (What is dizziness?). During the same period patient was treated with ROPINIROLE (ROPINIROL) ((2 Mg Qd) ; (4 Mg Qd) ; (6 Mg Qd) ; (8 Mg Qd) ; (10 Mg Qd)) (View Ropinirole (ropinirol) Review and Ropinirole (ropinirol) Label ), AZILECT ((1 Mg Qd)) (View Azilect Review and Azilect Label ), SIFROL (SIFROL) (NOT SPECIFIED) (See Image) (View Sifrol (sifrol) (not Specified) Review and Sifrol (sifrol) (not Specified) Label ). Patient was hospitalized and became disabled.

6652503-7 | Condition Aggravated, Parkinson's Disease
on Mar 12, 2010 Male patient from GERMANY , weighting 187.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient had the following side effects: condition aggravated, parkinson's disease (What is parkinson's disease?). Neupro dosage: (2 Mg Qd Transdermal), (4 Mg Qd Transdermal), (6 Mg Qd Transdermal). During the same period patient was treated with STALEVO 100 ((15/37.5/200 Mg Three Times Daily)) (View Stalevo 100 Review and Stalevo 100 Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ). Patient was hospitalized.

6652502-5 | Dyspnoea, Lung Disorder
on Mar 11, 2010 Female patient from GERMANY , weighting 198.4 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: dyspnoea, lung disorder. Neupro dosage: (4 Mg,qd Transdermal). During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PRAVASTATIN SODIUM (View Pravastatin Sodium Review and Pravastatin Sodium Label ). Patient was hospitalized.

6651466-8 | Chest Pain, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Delirium, Fall, Femur Fracture, Hip Fracture
Patient was taking Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), chronic obstructive pulmonary disease, condition aggravated, delirium, fall (What is fall?), femur fracture, hip fracture on Mar 09, 2010 from GERMANY Additional patient health information: Female patient , weighting 99.21 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: (2 Mg Qd Transdermal), (4 Mg Qd Transdermal). During the same period patient was treated with CARBIDOPA AND LEVODOPA ((100/25 Mg Once Daily), (200/50 Mg Once Daily), (200/50 Mg Twice Daily), (200/50 Mg Once Daily)) (View Carbidopa And Levodopa Review and Carbidopa And Levodopa Label ), LEVOCOMP (LEVODOPA COMP C) (NOT SPECIFIED) (See Image) (View Levocomp (levodopa Comp C) (not Specified) Review and Levocomp (levodopa Comp C) (not Specified) Label ). Patient was hospitalized.

6651309-2 | Acute Myocardial Infarction, Anxiety, Back Pain
Adverse event was reported on Mar 10, 2010 by a Female patient taking Neupro (View Usage) (Dosage: (2 Mg Qd), (4 Mg Qd), (6 Mg Qd), (8 Mg Qd)) was diagnosed with parkinson's disease (What is parkinson's disease?) and. Location: GERMANY , weighting 154.3 lb, Patient had the following side effects: acute myocardial infarction, anxiety (What is anxiety?), back pain (What is back pain?). During the same period patient was treated with LEVOCOMP (View Levocomp Review and Levocomp Label ), SIFROL (View Sifrol Review and Sifrol Label ), THIACIDE (View Thiacide Review and Thiacide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ). Patient was hospitalized.

6651259-1 | Aortic Valve Sclerosis, Aortic Valve Stenosis
on Mar 09, 2010 Male patient from GERMANY , weighting 169.8 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). After Neupro was administered, patient had the following side effects: aortic valve sclerosis, aortic valve stenosis. Neupro dosage: (2 Mg Qd Transdermal), (4 Mg Qd Transdermal), (6 Mg Qd Transdermal), (8 Mg Qd Transdermal). During the same period patient was treated with LEVODOPA COMP B (View Levodopa Comp B Review and Levodopa Comp B Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ).

6640224-6 | Acute Respiratory Failure
on Mar 08, 2010 Male patient from UNITED KINGDOM , 78 years of age, was diagnosed with parkinson's disease (What is parkinson's disease?) and was treated with Neupro (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure. Neupro dosage: (10 Mg Qd Trans Dermal). During the same period patient was treated with REQUIP (View Requip Review and Requip Label ), HYDROXOCOBALAMIN (View Hydroxocobalamin Review and Hydroxocobalamin Label ), BUMETANIDE (View Bumetanide Review and Bumetanide Label ), CO BENELDOPA (View Co-beneldopa Review and Co-beneldopa Label ), CO CARELDOPA (View Co-careldopa Review and Co-careldopa Label ), ENTACAPONE (View Entacapone Review and Entacapone Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ).

6610938-2 | Cholecystitis Acute
Patient was taking Neupro (View Usage). Patient had the following side effects: cholecystitis acute on Feb 10, 2010 from GERMANY Additional patient health information: Male patient , weighting 189.6 lb, was diagnosed with parkinson's disease (What is parkinson's disease?) and. Neupro dosage: 2 Mg Qd Transdermal. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AZILECT (View Azilect Review and Azilect Label ), DOPADURA C (View Dopadura C Review and Dopadura C Label ). Patient was hospitalized.